The distribution of structural neuropathology in pre-clinical Huntington’s disease

By Thieben M.J.  

Brain, Vol. 125, Iss. 8, 2002-08 ,pp. : 1815-1828

Oxford University Press

Access to resources Recommend Favorite

Thalamo-striatal diffusion reductions precede disease onset in prion mutation carriers

By Lee Hedok  

Brain, Vol. 132, Iss. 10, 2009-10 ,pp. : 2680-2687

Oxford University Press

Access to resources Recommend Favorite

Homozygosity for CAG mutation in Huntington disease is associated with a more severe clinical course

By Simpson S.A.  

Brain, Vol. 126, Iss. 4, 2003-04 ,pp. : 946-955

Oxford University Press

Access to resources Recommend Favorite

Cognitive changes in patients with Huntington’s disease (HD) and asymptomatic carriers of the HD mutation: A longitudinal follow–up study

By Lemiere J.   Decruyenaere M.   Evers-Kiebooms G.   Vandenbussche E.   Dom R.  

Journal of Neurology, Vol. 251, Iss. 8, 2004-08 ,pp. : 935-942

Springer Publishing Company

Access to resources Recommend Favorite

Impairments in source memory for olfactory and visual stimuli in preclinical and clinical stages of Huntington's disease

By Pirogovsky Eva   Gilbert Paul E.   Jacobson Mark   Peavy Guerry   Wetter Spencer   Goldstein Jody   Corey-Bloom Jody   Murphy Claire  

Journal of Clinical and Experimental Neuropsychology (Neuropsychology, Developm, Vol. 29, Iss. 4, 2007-05 ,pp. : 395-404

Routledge Ltd

Access to resources Recommend Favorite